85 related articles for article (PubMed ID: 20447087)
1. A psoriasiform rash.
Patalay R; Fields P; Kazmi M; Francis ND; Bunker CB
Clin Exp Dermatol; 2010 Mar; 35(2):209-10. PubMed ID: 20447087
[No Abstract] [Full Text] [Related]
2. Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin.
Ravandi F; Faderl S
Leuk Res; 2006 Jan; 30(1):103-5. PubMed ID: 15979704
[TBL] [Abstract][Full Text] [Related]
3. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H
Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271
[TBL] [Abstract][Full Text] [Related]
4. [A case of effective use of alemtuzumab in a male patient with T-cell lymphoma].
Sokolov AH; Parovichnikova EN; Isaev VG; Ustinova EN; Shavlokhov VS; Atopkov VA; Model SV; Tsyba NN; Kaplanskaia IB; Kliasova GA; Aleksanian MZh; Vishnevskaia ES; Togonidze DK; Mirzoian EE; Savchenko VG
Ter Arkh; 2004; 76(12):73-5. PubMed ID: 15724932
[No Abstract] [Full Text] [Related]
5. Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
Sohani AR; Ferry JA; Chang PS; Abramson JS
J Clin Oncol; 2010 Feb; 28(5):e69-72. PubMed ID: 19917859
[No Abstract] [Full Text] [Related]
6. [Antibody therapy in hematology and oncology - part 1].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
[No Abstract] [Full Text] [Related]
7. Acute T lymphoid and megakaryoblastic bi-lineal leukemia in a child.
Srinivas U; Saxena R; Bakhshi S
Indian Pediatr; 2007 Jul; 44(7):541-3. PubMed ID: 17684307
[TBL] [Abstract][Full Text] [Related]
8. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Mittal S; Milner BJ; Johnston PW; Culligan DJ
Eur J Haematol; 2006 Jun; 76(6):531-4. PubMed ID: 16548918
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL).
Vallera DA; Uckun FM
Prog Clin Biol Res; 1990; 333():191-204; discussion 205. PubMed ID: 2308981
[No Abstract] [Full Text] [Related]
10. Philadelphia chromosome (+) T-cell acute lymphoblastic leukemia after renal transplantation.
Arican A; Ozbek N; Baltaci V; Haberal M
Transplant Proc; 1999 Dec; 31(8):3242-3. PubMed ID: 10616462
[No Abstract] [Full Text] [Related]
11. [Treatment of adult T-cell leukemia-lymphoma].
Takatsuki K; Matsuzaki H; Matsuoka M
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):928-32. PubMed ID: 7525814
[No Abstract] [Full Text] [Related]
12. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
[No Abstract] [Full Text] [Related]
13. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
Zinzani PL; Alinari L; Tani M; Fina M; Pileri S; Baccarani M
Haematologica; 2005 May; 90(5):702-3. PubMed ID: 15921394
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange following mogamulizumab therapy before bone marrow transplantation in refractory adult T-cell leukemia-lymphoma.
Shimazu Y; Nohgawa M
Leuk Lymphoma; 2019 Dec; 60(12):3092-3093. PubMed ID: 31104532
[No Abstract] [Full Text] [Related]
16. Treatment of acute lymphoblastic leukemia.
Hoelzer D
Semin Hematol; 1994 Jan; 31(1):1-15. PubMed ID: 8122133
[No Abstract] [Full Text] [Related]
17. A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
Cencini E; Sozzi E; Sicuranza A; Fabbri A; Raspadori D; Lauria F; Forconi F
Br J Haematol; 2011 Jul; 154(2):271-4. PubMed ID: 21521181
[No Abstract] [Full Text] [Related]
18. Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine.
Osborne WL; Lennard AL
Haematologica; 2005 Jan; 90(1):ECR05. PubMed ID: 15653459
[TBL] [Abstract][Full Text] [Related]
19. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
[TBL] [Abstract][Full Text] [Related]
20. Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
Pratt G; Kinsey SE
Bone Marrow Transplant; 2001 Oct; 28(8):791-3. PubMed ID: 11781633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]